Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease

Ju Yeon Park, Jean Kyung Paik, Oh Yoen Kim, Jey Sook Chae, Yangsoo Jang, Jong Ho Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We determined the contribution of the combination of FEN1 10154G>T with the most significant association in the analysis of plasma arachidonic acid (AA, 20:4 ω6) and the APOA5 -1131T>C on phospholipid ω6PUFA and coronary artery disease (CAD). Patients with CAD (n = 807, 27-81 years of age) and healthy controls (n = 1123) were genotyped for FEN1 10154G>T and APOA5 -1131T>C. We found a significant interaction between these two genes for CAD risk ( P = 0.007) adjusted for confounding factors. APOA5 -1131C allele carriers had a higher CAD risk [odds ratio (OR):1.484, 95% confidence interval (CI):1.31-1.96; P = 0.005] compared with APOA5 -1131TT individuals in the FEN1 10154GG genotype group but not in the FEN1 10154T allele group (OR:1.096, 95%CI:0.84-1.43; P = 0.504). Signifi cant interactions between these two genes were also observed for the AA proportion ( P = 0.04) and the ratio of AA/ linoleic acid (LA, 18:2ω6) ( P = 0.004) in serum phospholipids of controls. The APOA5 -1131C allele was associated with lower AA ( P = 0.027) and AA/LA ( P = 0.014) only in controls carrying the FEN1 10154T allele. In conclusion, the interaction between these genes suggests that the FEN1 10154T variant allele decreases AA and AA/LA in the serum phospholipids of carriers of the APOA5 -1131C allele, but contributes no significant increase in CAD risk for this population subset despite their increased triglylcerides and decreased apoA5.

Original languageEnglish
Pages (from-to)3281-3288
Number of pages8
JournalJournal of Lipid Research
Volume51
Issue number11
DOIs
Publication statusPublished - 2010 Nov 1

Fingerprint

Polymorphism
Unsaturated Fatty Acids
Coronary Artery Disease
Phospholipids
Alleles
Serum
Genes
Odds Ratio
Confidence Intervals
Linoleic Acid
Set theory
Arachidonic Acid
Plasmas
Genotype
Population

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

@article{4e384bc7afcb4180914a0a7e2dd5542c,
title = "Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease",
abstract = "We determined the contribution of the combination of FEN1 10154G>T with the most significant association in the analysis of plasma arachidonic acid (AA, 20:4 ω6) and the APOA5 -1131T>C on phospholipid ω6PUFA and coronary artery disease (CAD). Patients with CAD (n = 807, 27-81 years of age) and healthy controls (n = 1123) were genotyped for FEN1 10154G>T and APOA5 -1131T>C. We found a significant interaction between these two genes for CAD risk ( P = 0.007) adjusted for confounding factors. APOA5 -1131C allele carriers had a higher CAD risk [odds ratio (OR):1.484, 95{\%} confidence interval (CI):1.31-1.96; P = 0.005] compared with APOA5 -1131TT individuals in the FEN1 10154GG genotype group but not in the FEN1 10154T allele group (OR:1.096, 95{\%}CI:0.84-1.43; P = 0.504). Signifi cant interactions between these two genes were also observed for the AA proportion ( P = 0.04) and the ratio of AA/ linoleic acid (LA, 18:2ω6) ( P = 0.004) in serum phospholipids of controls. The APOA5 -1131C allele was associated with lower AA ( P = 0.027) and AA/LA ( P = 0.014) only in controls carrying the FEN1 10154T allele. In conclusion, the interaction between these genes suggests that the FEN1 10154T variant allele decreases AA and AA/LA in the serum phospholipids of carriers of the APOA5 -1131C allele, but contributes no significant increase in CAD risk for this population subset despite their increased triglylcerides and decreased apoA5.",
author = "Park, {Ju Yeon} and Paik, {Jean Kyung} and Kim, {Oh Yoen} and Chae, {Jey Sook} and Yangsoo Jang and Lee, {Jong Ho}",
year = "2010",
month = "11",
day = "1",
doi = "10.1194/jlr.M010330",
language = "English",
volume = "51",
pages = "3281--3288",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. / Park, Ju Yeon; Paik, Jean Kyung; Kim, Oh Yoen; Chae, Jey Sook; Jang, Yangsoo; Lee, Jong Ho.

In: Journal of Lipid Research, Vol. 51, No. 11, 01.11.2010, p. 3281-3288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease

AU - Park, Ju Yeon

AU - Paik, Jean Kyung

AU - Kim, Oh Yoen

AU - Chae, Jey Sook

AU - Jang, Yangsoo

AU - Lee, Jong Ho

PY - 2010/11/1

Y1 - 2010/11/1

N2 - We determined the contribution of the combination of FEN1 10154G>T with the most significant association in the analysis of plasma arachidonic acid (AA, 20:4 ω6) and the APOA5 -1131T>C on phospholipid ω6PUFA and coronary artery disease (CAD). Patients with CAD (n = 807, 27-81 years of age) and healthy controls (n = 1123) were genotyped for FEN1 10154G>T and APOA5 -1131T>C. We found a significant interaction between these two genes for CAD risk ( P = 0.007) adjusted for confounding factors. APOA5 -1131C allele carriers had a higher CAD risk [odds ratio (OR):1.484, 95% confidence interval (CI):1.31-1.96; P = 0.005] compared with APOA5 -1131TT individuals in the FEN1 10154GG genotype group but not in the FEN1 10154T allele group (OR:1.096, 95%CI:0.84-1.43; P = 0.504). Signifi cant interactions between these two genes were also observed for the AA proportion ( P = 0.04) and the ratio of AA/ linoleic acid (LA, 18:2ω6) ( P = 0.004) in serum phospholipids of controls. The APOA5 -1131C allele was associated with lower AA ( P = 0.027) and AA/LA ( P = 0.014) only in controls carrying the FEN1 10154T allele. In conclusion, the interaction between these genes suggests that the FEN1 10154T variant allele decreases AA and AA/LA in the serum phospholipids of carriers of the APOA5 -1131C allele, but contributes no significant increase in CAD risk for this population subset despite their increased triglylcerides and decreased apoA5.

AB - We determined the contribution of the combination of FEN1 10154G>T with the most significant association in the analysis of plasma arachidonic acid (AA, 20:4 ω6) and the APOA5 -1131T>C on phospholipid ω6PUFA and coronary artery disease (CAD). Patients with CAD (n = 807, 27-81 years of age) and healthy controls (n = 1123) were genotyped for FEN1 10154G>T and APOA5 -1131T>C. We found a significant interaction between these two genes for CAD risk ( P = 0.007) adjusted for confounding factors. APOA5 -1131C allele carriers had a higher CAD risk [odds ratio (OR):1.484, 95% confidence interval (CI):1.31-1.96; P = 0.005] compared with APOA5 -1131TT individuals in the FEN1 10154GG genotype group but not in the FEN1 10154T allele group (OR:1.096, 95%CI:0.84-1.43; P = 0.504). Signifi cant interactions between these two genes were also observed for the AA proportion ( P = 0.04) and the ratio of AA/ linoleic acid (LA, 18:2ω6) ( P = 0.004) in serum phospholipids of controls. The APOA5 -1131C allele was associated with lower AA ( P = 0.027) and AA/LA ( P = 0.014) only in controls carrying the FEN1 10154T allele. In conclusion, the interaction between these genes suggests that the FEN1 10154T variant allele decreases AA and AA/LA in the serum phospholipids of carriers of the APOA5 -1131C allele, but contributes no significant increase in CAD risk for this population subset despite their increased triglylcerides and decreased apoA5.

UR - http://www.scopus.com/inward/record.url?scp=78149311473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149311473&partnerID=8YFLogxK

U2 - 10.1194/jlr.M010330

DO - 10.1194/jlr.M010330

M3 - Article

C2 - 20802161

AN - SCOPUS:78149311473

VL - 51

SP - 3281

EP - 3288

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 11

ER -